The Biomarker Working Group is a consortium of investigators with a shared interest in discovery and validation of biomarkers for type 1 diabetes. Specifically, we focus on biomarkers that can predict disease onset or loss of c-peptide. We also have a strong interest in biomarkers that could stratify recent-onset patients prior to enrollment in clinical trials or serve as surrogates for clinical outcome. Our scientific goals may evolve as new members are added.
To apply for BWG membership, please submit the attached form. You can expect a turnaround time of 4-6 weeks.